Short-acting β2-agonist use in asthma in Western societies

被引:1
|
作者
Quint, Jennifer [1 ]
Arnetorp, Sofie [2 ]
Janson, Christer [3 ]
Boarino, Silvia [4 ]
Kocks, Jan Willem [5 ]
Gilbert, Ileen [6 ]
Kupczyk, Maciej [7 ]
Nuevo, Javier [8 ]
Lugogo, Njira Lucia [9 ]
Penz, Erika [10 ]
Quirce, Santiago [11 ,12 ]
Raherison-Semjen, Chantal [13 ]
Van der Valk, Ralf [14 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England
[2] AstraZeneca, Gothenburg, Sweden
[3] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
[4] AstraZeneca, Milan, Italy
[5] Gen Practitioners Res Inst, Groningen, Netherlands
[6] AstraZeneca, Wilmington, DE USA
[7] Med Univ Lodz, Barlicki Univ Hosp, Dept Internal Med Asthma & Allergy, Lodz, Poland
[8] AstraZeneca, Madrid, Spain
[9] Univ Michigan, Dept Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[10] Univ Saskatchewan, Dept Med, Div Respirol Crit Care & Sleep Med, Saskatoon, SK, Canada
[11] La Paz Univ Hosp, Dept Allergy, Madrid, Spain
[12] CIBER Resp Dis CIBERES, Madrid, Spain
[13] Bordeaux Univ, CHU Bordeaux, Dept Pulm Med, INSERM U1219, Bordeaux, France
[14] AstraZeneca, Cambridge, England
关键词
Exacerbation; Asthma; Airway management;
D O I
10.1183/13993003.congress-2020.2629
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2629
引用
收藏
页数:2
相关论文
共 50 条
  • [1] SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries
    Christer Janson
    Andrew Menzies-Gow
    Cassandra Nan
    Javier Nuevo
    Alberto Papi
    Jennifer K. Quint
    Santiago Quirce
    Claus F. Vogelmeier
    [J]. Advances in Therapy, 2020, 37 : 1124 - 1135
  • [2] SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries
    Janson, Christer
    Menzies-Gow, Andrew
    Nan, Cassandra
    Nuevo, Javier
    Papi, Alberto
    Quint, Jennifer K.
    Quirce, Santiago
    Vogelmeier, Claus F.
    [J]. ADVANCES IN THERAPY, 2020, 37 (03) : 1124 - 1135
  • [3] Factors associated with high short-acting β2-agonist use in urban children with asthma
    Butz, Arlene M.
    Ogborn, Jean
    Mudd, Shawna
    Ballreich, Jeromie
    Tsoukleris, Mona
    Kub, Joan
    Bellin, Melissa
    Bollinger, Mary Elizabeth
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (05) : 385 - 392
  • [4] Asthma control in the United StatesRelationships between short-acting β2-agonist and systemic corticosteroid use
    Chupp, Geoffrey
    Murphy, Kevin R.
    Gandhi, Hitesh N.
    Gilbert, Ileen
    Bleecker, Eugene R.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (03) : 302 - 309
  • [5] Short-acting β2-agonist use and asthma exacerbations in Swedish children: A SABINA Junior study
    Melen, Erik
    Nwaru, Bright, I
    Wiklund, Fredrik
    Licht, Sofie de Fine
    Telg, Gunilla
    Maslova, Ekaterina
    van der Valk, Ralf J. P.
    Tran, Trung N.
    Ekstrom, Magnus
    Janson, Christer
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 (11)
  • [6] The Burden of Short-Acting β2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
    Fabiano Di Marco
    Mariella D’Amato
    Francesco P. Lombardo
    Claudio Micheletto
    Franca Heiman
    Valeria Pegoraro
    Silvia Boarino
    Giandomenico Manna
    Francesca Mastromauro
    Simona Spennato
    Alberto Papi
    [J]. Advances in Therapy, 2021, 38 : 3816 - 3830
  • [7] The Burden of Short-Acting β2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
    Di Marco, Fabiano
    D'Amato, Mariella
    Lombardo, Francesco P.
    Micheletto, Claudio
    Heiman, Franca
    Pegoraro, Valeria
    Boarino, Silvia
    Manna, Giandomenico
    Mastromauro, Francesca
    Spennato, Simona
    Papi, Alberto
    [J]. ADVANCES IN THERAPY, 2021, 38 (07) : 3816 - 3830
  • [8] SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma
    Cabrera, Claudia S.
    Nan, Cassandra
    Lindarck, Niklas
    Beekman, Maarten J. H., I
    Arnetorp, Sofie
    van der Valk, Ralf J. P.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (02)
  • [9] Predictors of excessive short-acting β2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database
    Kupczyk, Maciej
    Barg, Wojciech
    Bochenek, Grazyna
    Brozek, Grzegorz
    Dabrowiecki, Piotr
    Brzostek, Dorota
    Dabrowski, Andrzej
    Dobek, Rafal
    Gawlik, Radoslaw
    Kucharczyk, Aleksandra
    Kuprys-Lipinska, Izabela
    Mastalerz-Migas, Agnieszka
    Kowalski, Marek L.
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 790 - 797
  • [10] Editorial comment on: Short-acting β 2-agonist use and asthma exacerbations in Swedish children: A SABINA Junior study
    Boccabella, Cristina
    Kalayci, Omer
    Eigenmann, Philippe
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2023, 34 (01)